EOLS Q1 2021 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena

EOLSEvolus, Inc.

$353M

Q1 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$12M+16.6% YoY

Gross Profit

$7M59.9% margin

Operating Income

$8M65.6% margin

Net Income

$6M52.3% margin

EPS (Diluted)

$0.16

QoQ Revenue Growth

-40.5%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$157M

Total Liabilities

$134M

Stockholders' Equity

$23M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$10M	+16.6%
Gross Profit	$7M	$5M	+61.9%
Operating Income	$8M	-$27M	+129.4%
Net Income	$6M	-$20M	+132.4%